+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Monitoring of occupational and environmental aeroallergens-- EAACI Position Paper. Concerted action of the EAACI IG Occupational Allergy and Aerobiology & Air Pollution



Monitoring of occupational and environmental aeroallergens-- EAACI Position Paper. Concerted action of the EAACI IG Occupational Allergy and Aerobiology & Air Pollution



Allergy 69(10): 1280-1299



Exposure to high molecular weight sensitizers of biological origin is an important risk factor for the development of asthma and rhinitis. Most of the causal allergens have been defined based on their reactivity with IgE antibodies, and in many cases, the molecular structure and function of the allergens have been established. Significant information on allergen levels that cause sensitization and allergic symptoms for several major environmental and occupational allergens has been reported. Monitoring of high molecular weight allergens and allergen carrier particles is an important part of the management of allergic respiratory diseases and requires standardized allergen assessment methods for occupational and environmental (indoor and outdoor) allergen exposure. The aim of this EAACI task force was to review the essential points for monitoring environmental and occupational allergen exposure including sampling strategies and methods, processing of dust samples, allergen analysis, and quantification. The paper includes a summary of different methods for sampling and allergen quantification, as well as their pros and cons for various exposure settings. Recommendations are being made for different exposure scenarios.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 054455316

Download citation: RISBibTeXText

PMID: 24894737

DOI: 10.1111/all.12456


Related references

EAACI position paper on occupational rhinitis. Respiratory Research 10: 16-16, 2009

Occupational hypersensitivity pneumonitis: an EAACI position paper. Allergy 71(6): 765-779, 2016

EAACI position paper: skin prick testing in the diagnosis of occupational type I allergies. Allergy 68(5): 580-584, 2013

A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 56(9): 813-824, 2001

Research needs in allergy: an EAACI position paper, in collaboration with EFA. Clinical and Translational Allergy 2(1): 21-21, 2012

AllergoOncology - the impact of allergy in oncology: EAACI position paper. Allergy 72(6): 866-887, 2016

Vaccination and allergy: EAACI position paper, practical aspects. Pediatric Allergy and Immunology 28(7): 628-640, 2017

Position paper of the EAACI: food allergy due to immunological cross-reactions with common inhalant allergens. Allergy 70(9): 1079-1090, 2016

Skin test concentrations for systemically administered drugs -- an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy 68(6): 702-712, 2013

Rvision de la nomenclature de l'allergie (version longue) Prise de position de l'EAACI par le groupe de l'EAACI charg de la nomenclature. Revue Française D'allergologie et D'immunologie Clinique 44(2): 218-230, 2004

Drug allergy passport and other documentation for patients with drug hypersensitivity - An ENDA/EAACI Drug Allergy Interest Group Position Paper. Allergy 71(11): 1533-1539, 2016

Desensitization in delayed drug hypersensitivity reactions -- an EAACI position paper of the Drug Allergy Interest Group. Allergy 68(7): 844-852, 2013

In vitro tests for drug hypersensitivity reactions: an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy 71(8): 1103-1134, 2016

Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper. Allergy 72(8): 1156-1173, 2017

AAAAI support of the EAACI Position Paper on IgG4. Journal of Allergy and Clinical Immunology 125(6): 1410-1410, 2010